03 November 2016
: Case report 
Extensively Drug-Resistant Tuberculosis: Report and Literature Review on Two Cases Requiring Prolonged Treatment
Unusual clinical course, Patient complains / malpractice, Educational Purpose (only if useful for a systematic review or synthesis)
Martha Matos-TocascaABDEFG, Gabriel De la Cruz-KuABDEF, Erick AuccacusiABDEF, Diego Fernandez-SalasABDEF, Tatiana García-AhuanariABDEF, Bryan Valcarcel-ValdiviaABDEFDOI: 10.12659/AJCR.900001
Am J Case Rep 2016; 17:819-826
Abstract
BACKGROUND: Extensively drug-resistant tuberculosis (XDR-TB) is a global problem due to the high morbidity and mortality it causes. Peru is one of the countries with the highest numbers of cases of XDR-TB, which increase every year.
CASE REPORT: We present the case of two siblings who developed XDR-TB, underwent surgery twice, and were in individualized treatment for more than 6 years. Finally they achieved remission of symptoms, despite not having standardized treatment schemes during their diagnosis period.
CONCLUSIONS: Extensively drug-resistant tuberculosis can be cured with a treatment that involves both medical care and patient actions to achieve remission of the disease.
Keywords: Extensively Drug-Resistant Tuberculosis, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945106
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945253
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945053
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945238
Most Viewed Current Articles
21 Jun 2024 : Case report
57,486
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
42,466
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 
32,431
DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
23 Feb 2022 : Case report
19,902
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250